Top Biz News

China to scrutinize drug prices

By Shan Juan (China Daily)
Updated: 2007-02-27 09:42

"They have to behave morally and be honest and quite experienced in drug supervision," the SFDA posting said.

However, the credibility of GMP certification has been called into question in the wake of repeated health crises caused by low-quality pharmaceuticals.

The SFDA announced a campaign in January to re-examine drug companies who had acquired a GMP certificate for registering new medicines in 2004 and 2005.

(China Daily 02/27/2007 page3)